scholarly journals Phase 2 Trial of Capecitabine, Gemcitabine, and Bevacizumab in Sarcomatoid Renal-Cell Carcinoma

2018 ◽  
Vol 16 (1) ◽  
pp. e47-e57 ◽  
Author(s):  
Abhishek Maiti ◽  
Maryam Nemati-Shafaee ◽  
Pavlos Msaouel ◽  
Lance C. Pagliaro ◽  
Eric Jonasch ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Renal Cell ◽  
Phase 2 ◽  
Phase 2 Trial ◽  
Sarcomatoid Renal Cell Carcinoma

scholarly journals Everolimus versus sunitinib for patients with metastatic non-clear cell renal cell carcinoma (ASPEN): a multicentre, open-label, randomised phase 2 trial

2016 ◽  
Vol 17 (3) ◽  
pp. 378-388 ◽  
Author(s):  
Andrew J Armstrong ◽  
Susan Halabi ◽  
Tim Eisen ◽  
Samuel Broderick ◽  
Walter M Stadler ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Renal Cell ◽  
Clear Cell ◽  
Phase 2 ◽  
Open Label ◽  
Cell Renal Cell Carcinoma ◽  
Phase 2 Trial

Regorafenib for patients with previously untreated metastatic or unresectable renal-cell carcinoma: a single-group phase 2 trial

2012 ◽  
Vol 13 (10) ◽  
pp. 1055-1062 ◽  
Author(s):  
Tim Eisen ◽  
Heikki Joensuu ◽  
Paul D Nathan ◽  
Peter G Harper ◽  
Marek Z Wojtukiewicz ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Renal Cell ◽  
Phase 2 ◽  
Single Group ◽  
Phase 2 Trial

Active surveillance in metastatic renal-cell carcinoma: a prospective, phase 2 trial

2016 ◽  
Vol 17 (9) ◽  
pp. 1317-1324 ◽  
Author(s):  
Brian I Rini ◽  
Tanya B Dorff ◽  
Paul Elson ◽  
Cristina Suarez Rodriguez ◽  
Dale Shepard ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Active Surveillance ◽  
Metastatic Renal Cell Carcinoma ◽  
Renal Cell ◽  
Phase 2 ◽  
Phase 2 Trial ◽  
Prospective Phase

scholarly journals Phase 2 Trial of Neoadjuvant Axitinib in Patients with Locally Advanced Nonmetastatic Clear Cell Renal Cell Carcinoma

2014 ◽  
Vol 66 (5) ◽  
pp. 874-880 ◽  
Author(s):  
Jose A. Karam ◽  
Catherine E. Devine ◽  
Diana L. Urbauer ◽  
Marisa Lozano ◽  
Tapati Maity ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Renal Cell ◽  
Clear Cell ◽  
Locally Advanced ◽  
Phase 2 ◽  
Cell Renal Cell Carcinoma ◽  
Phase 2 Trial

scholarly journals Axitinib with or without dose titration for first-line metastatic renal-cell carcinoma: a randomised double-blind phase 2 trial

2013 ◽  
Vol 14 (12) ◽  
pp. 1233-1242 ◽  
Author(s):  
Brian I Rini ◽  
Bohuslav Melichar ◽  
Takeshi Ueda ◽  
Viktor Grünwald ◽  
Mayer N Fishman ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Metastatic Renal Cell Carcinoma ◽  
Renal Cell ◽  
Dose Titration ◽  
Phase 2 ◽  
First Line ◽  
Double Blind ◽  
Phase 2 Trial
Sign in / Sign up

Export Citation Format

Share Document